Evidence map›Paper›PMID 35613801›Full record

ArticleBMJ open2022

Efficacy and safety of endovenous microwave ablation versus laser ablation for great saphenous vein varicosis: study protocol for a multicentre, randomised controlled non-inferiority trial.

Yongjun Li, Weiwei Wu, Younan Li, Jing Li, Mengnan Sun

2 registry-linked trialsOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04726124 naunknown statusnot on this map

A Prospective, Multicenter, Randomized, Controlled Clinical Trial to Validate the Safety and Efficacy of Microwave Versus Laser Ablation of the Great Saphenous Vein in Patients With Varicose Veins

TypeinterventionalSponsorBeijing Tsinghua Chang Gung HospitalRan2021 to 2022Enrolled180ConditionsVaricose Veins of Lower LimbArmsMicrowave Ablation Therapeutic Apparatus
NCT06693245 recruitingnot on this mapstarted 2024, after this paper: background citation

Observation of Pain During the Treatment of Great Saphenous Vein Using Microwave Ablation, and Analysis of Related Factors

Typeobservational_patient_registrySponsorChengdu University of Traditional Chinese MedicineRan2024 to 2025Enrolled155ConditionsVascular Disease,Peripheral, Venous Insufficiency of Leg, Varicose Veins of Lower LimbArmsVAS scores of the puncture
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Endovenous laser treatmentWorld journal of clinical cases · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Yongjun LiDepartment of Vascular Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Weiwei WuDepartment of Vascular Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China Weiweidoc_bjedu@hotmail.com.ORCID 0000-0002-1908-3905
Younan LiDepartment of Vascular Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Jing LiGeneral Manager Office, Beijing Sanhe Dingye Technology Co., Ltd, Beijing, China.
Mengnan SunDepartment of Clinical and Registration Affairs, Beijing Sanhe Dingye Technology Co., Ltd, Beijing, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNBeijing Tsinghua Chang Gung Hospital · CNOffice of Management · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEndovenous microwave ablation (EMA) is a relatively novel thermal ablation treatment for great saphenous vein (GSV) varicosis, and its efficacy and safety are rarely reported. This study aims to explore whether EMA can be comparable to endovenous laser ablation (EVLA), which is a widely used thermal ablation treatment in clinical practice. METHODS AND ANALYSIS: This is a multicentre, randomised controlled non-inferiority trial to compare the efficacy and safety of EMA and EVLA in patients with GSV varicosis. We will recruit 180 patients in 6 centres and randomly assign them into treatment group (EMA group) and control group (EVLA group) in a 1:1 ratio. The patients will return to the hospitals at 7 days, 3 months, 6 months and 12 months, and will be called at 1 month after the treatment for follow-up visits. The primary outcome is the occlusion rate of GSV immediately, at 6 months, and at 12 months after the treatment. The secondary outcomes are Venous Clinical Severity Score (VCSS), Aberdeen Varicose Vein Questionnaire (AVVQ) Score, operation time and instrument performance evaluation. ETHICS AND DISSEMINATION: This protocol has been approved by the Clinical Trial Ethics Committee of Beijing Hospital (2020BJYYEC-126-02), Peking Union Medical College Hospital (KS2020393), Beijing Tsinghua Changgung Hospital (No.20279-2-02), Beijing Luhe Hospital.Capital Medical University (2020-LHYW-030-01), the First Hospital of Hebei Medical University (No.2020249), and the First Affiliated Hospital of Xi'an Jiaotong University (XJTU1AF2021LSY-12). The trial results will be published in peer-reviewed journals. TRIAL REGISTRATION NUMBER: NCT04726124.

Indexed as

Endovascular ProceduresLaser TherapySaphenous VeinVaricose VeinsEquivalence Trials as TopicHumansMicrowavesMulticenter Studies as TopicNeoplasm Recurrence, LocalRandomized Controlled Trials as TopicTreatment OutcomeEPIDEMIOLOGYProtocols & guidelinesVascular medicine

Identifiers

PMID35613801
PMCPMC9134177
OpenAlexW4281487146

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.